Press Releases May 27, 2026 07:00 AM

Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026

Balchem Corporation to Present at Wells Fargo Industrials Conference on June 10, 2026

By Ajmal Hussain BCPC

Balchem Corporation announced its participation in the Wells Fargo Industrials Conference on June 10, 2026, where key executives including the CEO, CFO, and Senior Director of Investor Relations will present. The company is a global specialty ingredient manufacturer serving health and nutrition markets with three main business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
BCPC

Key Points

  • Balchem Corporation will participate in the Wells Fargo Industrials Conference, allowing direct communication with investors and analysts.
  • The company operates in three main segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, serving diverse industries such as food, supplements, pharmaceuticals, animal health, and agriculture.
  • Top leadership, including the CEO and CFO, will engage with the market, potentially highlighting recent developments and future strategies.

MONTVALE, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the Wells Fargo Industrials Conference on June 10, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference.

About Balchem Corporation

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Contact:Jacqueline Yarmolowicz Balchem Corporation (Telephone: 845-326-5600)



Risks

  • Market reaction is uncertain as this is primarily an investor relations event without new product or financial announcements.
  • The company operates in multiple sectors (nutrition, animal health, specialty chemicals), exposing it to sector-specific regulatory and supply chain risks.
  • Economic or market conditions may impact the effective reception of the company’s presentation at the conference.

More from Press Releases

LiqTech International Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Jun 4, 2026 Correction: Keystone Acquisition Corp. Announces Closing of $287.5 Million Initial Public Offering Including Exercise of Underwriters’ Over-Allotment Option Jun 4, 2026 Verizon declares quarterly dividend on June 4, 2026 Jun 4, 2026 AmperCap Acquisition Company Completes its $125,000,000 Initial Public Offering Jun 4, 2026 Algoma Steel Releases 2025 Sustainability Report Jun 4, 2026